Latest IDRA reports update at 2023-06-29: 2023-Q12022-Q42022-Q1
Idera Pharmaceuticals logo
Idera Pharmaceuticals IDRA
$ 0.43 -23.04%

Idera Pharmaceuticals Financial Ratios 2011-2024 | IDRA

Annual Financial Ratios Idera Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.1 0.0 -1.7 -0.9 -1.2 -4.4 -4.5 -4.6 -9.7 -9.9 -1.0 -1.3

P/S

0.3 - - 33.9 106.5 322.8 10.6 896.7 5128.5 3848.8 390.2 562.9

EPS

-7.2 33.5 -3.3 -3.0 -2.2 -0.4 -0.3 -0.4 -0.5 -0.5 -0.8 -1.0

EV (Enterprise Value)

51.5 M -25.5 M 289 M 67.7 M 8.09 M 189 M 101 M 205 M 362 M 159 M 14 M 18.8 M

EBITDA per Share

-8.51 -9.53 -1.08 -1.6 -2.11 -3.34 -2.39 -3.36 -3.72 -3.29 -5.69 -7.34

EV/EBITDA

1.0 -4.3 -0.2 0.0 -2.7 -2.4 -4.1 -9.2 -8.6 -0.5 -0.2

PEG

-0.0 0.0 -0.13 -0.03 0.04 -0.11 0.16 0.43 4.65 0.24 0.05 -0.03

P/B

0.0 0.1 -2.1 -4.4 1.1 2.7 1.7 2.7 8.6 5.6 3.0 2.5

P/CF

-0.1 -0.1 -5.6 -1.1 -1.4 -5.2 -6.0 -5.1 -11.5 -10.6 -1.0 -1.6

ROE %

-197.53 333.04 123.57 506.04 -93.57 -61.27 -37.15 -58.09 -89.03 -56.16 -290.33 -197.74

ROA %

-23.10 281.35 -265.72 -119.01 -82.00 -55.72 -33.90 -52.62 -75.14 -49.44 -177.77 -92.89

ROCE %

-235.23 -93.96 -103.72 652.90 -88.43 -61.37 -37.31 -57.16 -87.32 -55.98 -297.38 -132.52

Current Ratio

1.6 6.4 5.9 0.8 8.1 11.5 11.9 9.3 6.0 6.9 2.5 4.1

DSO

158.0 - - - - - - - - - - -

DIO

- - - - - - - - - - - -

DPO

- - - - - - - - - - - -

Operating Cycle

157.9 - - - - - - - - - - -

Cash Conversion Cycle

157.9 - - - - - - - - - - -

All numbers in USD currency

Quarterly Financial Ratios Idera Pharmaceuticals

2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-2.94 - -0.06 -0.1 -1.34 - -0.11 -0.15 2.66 - -0.59 -0.72 0.27 - -0.39 -0.39 -0.4 - -0.43 -0.59 -0.81 - -0.78 -1.15 -0.1 - -0.1 -0.11 -0.11 - -0.1 -0.11 -0.12 - -0.11 -0.1 -0.12 - -0.11 -0.15 -0.15 - -0.17 -0.15 -0.25 - -0.2 -0.23 -0.25

EBITDA per Share

-2.77 - -0.17 -0.1 -1.34 - -0.11 -0.15 -0.24 - -0.21 -0.24 -0.43 - -0.39 -0.4 -0.41 - -0.43 -0.6 -0.81 - -0.77 -1.15 -0.1 - -0.11 -0.11 -0.11 - -0.1 -0.11 -0.12 - -0.11 -0.1 -0.12 - -0.1 -0.09 -0.14 - -0.17 -0.19 -0.2 - -0.2 -0.22 -0.24

ROE %

-151.94 -56.20 -74.27 -77.42 -72.35 235.47 258.01 298.62 345.24 39.44 139.13 216.27 289.77 298.02 279.89 162.07 36.94 -74.59 -88.08 -83.44 -78.32 -47.41 -59.89 -58.89 -52.00 -37.94 -51.54 -52.65 -54.82 -43.75 -65.53 -73.72 -77.64 -61.57 -76.17 -68.99 -60.91 -37.40 -698.73 -1345.46 -1884.96 -2187.25 -2232.90 -1617.22 -1118.90 -154.82 -45.65 -52.25 -56.93

ROA %

-54.01 -37.03 -52.25 -64.49 -61.34 208.83 160.35 127.11 87.00 -84.82 -108.26 -83.23 -49.63 -70.09 -85.98 -78.43 -76.85 -65.36 -77.63 -74.01 -70.19 -43.12 -54.51 -53.64 -47.42 -34.63 -46.95 -47.87 -49.74 -39.63 -58.01 -64.08 -66.45 -51.97 -64.82 -59.28 -52.87 -32.92 -76.06 -106.35 -132.52 -142.68 -164.12 -142.43 -131.06 -72.73 -21.45 -24.54 -26.74

ROCE %

-115.21 -86.48 -104.56 -77.73 -72.37 -61.81 -53.60 -27.32 1.50 31.42 133.38 227.13 321.46 306.94 288.38 167.85 39.26 -75.73 -89.34 -84.40 -78.98 -47.77 -60.33 -59.26 -52.38 -38.22 -51.94 -53.10 -55.22 -43.98 -65.92 -74.14 -78.05 -61.80 -76.23 -68.72 -60.52 -37.28 -710.36 -1369.02 -2112.14 -2205.24 -2250.40 -1622.47 -919.63 -153.23 -45.16 -51.26 -56.81

Current Ratio

1.4 1.6 1.9 5.1 7.0 6.4 6.3 6.6 8.4 0.3 0.3 0.3 0.3 0.8 0.8 0.8 0.8 8.1 8.1 8.1 8.1 11.0 11.0 11.0 11.0 11.5 11.5 11.5 11.5 10.6 10.6 10.6 10.6 6.4 6.4 6.4 6.4 8.3 8.3 8.3 8.3 2.6 2.6 2.6 2.6 3.4 3.4 3.4 3.4

DSO

118.4 - 1828.7 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

118.4 - 1828.7 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

118.4 - 1828.7 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency